HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease

Jeremy Adler, Joseph A. Galanko, Rana Ammoury, Keith J. Benkov, Athos Bousvaros, Brendan Boyle, José M. Cabrera, Kelly Y. Chun, Jill Dorsey, Dawn R. Ebach, Ann M. Firestine, Ajay S. Gulati, Hans H. Herfarth, Traci W. Jester, Jess L. Kaplan, Ian Leibowitz, Tiffany M. Linville, Peter A. Margolis, Phillip Minar, Zarela Molle-RiosJonathan Moses, Kelly Olano, Dinesh S. Pashankar, Lisa Pitch, Shehzad A. Saeed, Charles M. Samson, Kelly Sandberg, Steven J. Steiner, Jennifer A. Strople, Jillian S. Sullivan, Prateek D. Wali, Michael D. Kappelman

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number10.14309/ajg.0000000000003135
JournalAmerican Journal of Gastroenterology
DOIs
StateAccepted/In press - 2024
Externally publishedYes

ASJC Scopus Subject Areas

  • Hepatology
  • Gastroenterology

Cite this